Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics

Journal of Immunology

Volumn 186, Issue 5, 2011, Pages 2950-2958

  Borbulevych, Oleg Y ^a   Piepenbrink, Kurt H ^a   Baker, Brian M ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MYELIN BASIC PROTEIN; PROTEIN HUD; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGEN STRUCTURE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL SURVIVAL; CIRCULAR DICHROISM; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CROSS REACTION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; MOLECULAR MIMICRY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; THERMOSTABILITY;

ANTIGEN PRESENTATION; AUTOANTIGENS; CLONE CELLS; CONSERVED SEQUENCE; CROSS REACTIONS; CRYSTALLOGRAPHY, X-RAY; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, TAX; HLA-A2 ANTIGEN; HTLV-I ANTIGENS; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; MOLECULAR MIMICRY; NEURONS; PARAPARESIS, TROPICAL SPASTIC; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STABILITY; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 79952743743     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003150     Document Type: Article

References (58)

1. Oldstone, M. B. A. 1998. Molecular mimicry and immune-mediated diseases. FASEB J. 12: 1255-1265. (Pubitemid 28475568)
2. Kohm, A. P., K. G. Fuller, and S. D. Miller. 2003. Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology. Trends Microbiol. 11: 101-105.
3. Wucherpfennig, K. W. 2001. Structural basis of molecular mimicry. J. Autoimmun. 16: 293-302. (Pubitemid 32566118)
4. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384: 134-141. (Pubitemid 26386462)
5. Hahn, M., M. J. Nicholson, J. Pyrdol, and K. W. Wucherpfennig. 2005. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat. Immunol. 6: 490-496.
6. Li, Y., Y. Huang, J. Lue, J. A. Quandt, R. Martin, and R. A. Mariuzza. 2005. Structure of a human autoimmune TCR bound to a myelin basic protein selfpeptide and a multiple sclerosis-associated MHC class II molecule. EMBO J. 24: 2968-2979.
7. Maynard, J., K. Petersson, D. H. Wilson, E. J. Adams, S. E. Blondelle, M. J. Boulanger, D. B. Wilson, and K. C. Garcia. 2005. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity 22: 81-92.
8. Feng, D., C. J. Bond, L. K. Ely, J. Maynard, and K. C. Garcia. 2007. Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction 'codon.' Nat. Immunol. 8: 975-983.
9. He, X. L., C. Radu, J. Sidney, A. Sette, E. S. Ward, and K. C. Garcia. 2002. Structural snapshot of aberrant antigen presentation linked to autoimmunity: the immunodominant epitope of MBP complexed with I-Au. Immunity 17: 83-94.
10. Gras, S., X. Saulquin, J.-B. Reiser, E. Debeaupuis, K. Echasserieau, A. Kissenpfennig, F. Legoux, A. Chouquet, M. Le Gorrec, P. Machillot, et al. 2009. Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope. J. Immunol. 183: 430-437.
11. Wucherpfennig, K. W., M. J. Call, L. Deng, and R. Mariuzza. 2009. Structural alterations in peptide-MHC recognition by self-reactive T cell receptors. Curr. Opin. Immunol. 21: 590-595.
12. Deng, L., and R. A. Mariuzza. 2007. Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors. Trends Biochem. Sci. 32: 500-508.
13. Borbulevych, O. Y., K. H. Piepenbrink, B. E. Gloor, D. R. Scott, R. F. Sommese, D. K. Cole, A. K. Sewell, and B. M. Baker. 2009. T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility. Immunity 31: 885-896.
14. Macdonald, W. A., Z. Chen, S. Gras, J. K. Archbold, F. E. Tynan, C. S. Clements, M. Bharadwaj, L. Kjer-Nielsen, P. M. Saunders, M. C. J. Wilce, et al. 2009. T cell allorecognition via molecular mimicry. Immunity 31: 897-908.
15. Beckett, D. 2004. Functional switches in transcription regulation; molecular mimicry and plasticity in protein-protein interactions. Biochemistry 43: 7983-7991. (Pubitemid 38808252)
16. Harkiolaki, M., S. L. Holmes, P. Svendsen, J. W. Gregersen, L. T. Jensen, R. McMahon, M. A. Friese, G. van Boxel, R. Etzensperger, J. S. Tzartos, et al. 2009. T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity 30: 348-357.
17. Degano, M., K. C. Garcia, V. Apostolopoulos, M. G. Rudolph, L. Teyton, and I. A. Wilson. 2000. A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. Immunity 12: 251-261.
18. Colf, L. A., A. J. Bankovich, N. A. Hanick, N. A. Bowerman, L. L. Jones, D. M. Kranz, and K. C. Garcia. 2007. How a single T cell receptor recognizes both self and foreign MHC. Cell 129: 135-146.
19. Gagnon, S. J., O. Y. Borbulevych, R. L. Davis-Harrison, R. V. Turner, M. Damirjian, A. Wojnarowicz, W. E. Biddison, and B. M. Baker. 2006. T cell receptor recognition via cooperative conformational plasticity. J. Mol. Biol. 363: 228-243.
20. Ding, Y. H., B. M. Baker, D. N. Garboczi, W. E. Biddison, and D. C. Wiley. 1999. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity 11: 45-56.
21. Hausmann, S., W. E. Biddison, K. J. Smith, Y. H. Ding, D. N. Garboczi, U. Utz, D. C. Wiley, and K. W. Wucherpfennig. 1999. Peptide recognition by two HLAA2/ Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures. J. Immunol. 162: 5389-5397.
22. Gagnon, S. J., R. V. Turner, M. G. Shiue, M. Damirjian, and W. E. Biddison. 2006. Extensive T cell receptor cross-reactivity on structurally diverse haptenated peptides presented by HLA-A2. Mol. Immunol. 43: 346-356.
23. Laugel, B., J. M. Boulter, N. Lissin, A. Vuidepot, Y. Li, E. Gostick, L. E. Crotty, D. C. Douek, J. Hemelaar, D. A. Price, et al. 2005. Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibition. J. Biol. Chem. 280: 1882-1892.
24. Levin, M. C., and S. Jacobson. 1997. HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J. Neurovirol. 3: 126-140. (Pubitemid 27182506)
25. Plumelle, Y. 1999. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis hypothesis. A shift of homologous peptides pairs, central nervous system (CNS)/HTLF-1, HTLV-1/thymus, thymus/CNS, in a thymus-like CNS environment, underlies the pathogenesis of HAM/TSP. Med. Hypotheses 52: 595-604.
26. Greten, T. F., J. E. Slansky, R. Kubota, S. S. Soldan, E. M. Jaffee, T. P. Leist, D. M. Pardoll, S. Jacobson, and J. P. Schneck. 1998. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc. Natl. Acad. Sci. USA 95: 7568-7573.
27. Bieganowska, K., P. Höllsberg, G. J. Buckle, D.-G. Lim, T. F. Greten, J. Schneck, J. D. Altman, S. Jacobson, S. L. Ledis, B. Hanchard, et al. 1999. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J. Immunol. 162: 1765-1771. (Pubitemid 29307056)
28. Utz, U., D. Banks, S. Jacobson, and W. E. Biddison. 1996. Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion. J. Virol. 70: 843-851.
29. Motyka, B., and H.-S. Teh. 1998. Naturally occurring low affinity peptide/MHC class I ligands can mediate negative selection and T cell activation. J. Immunol. 160: 77-86. (Pubitemid 28116717)
30. Davis-Harrison, R. L., K. M. Armstrong, and B. M. Baker. 2005. Two different T cell receptors use different thermodynamic strategies to recognize the same peptide/MHC ligand. J. Mol. Biol. 346: 533-550.
31. Boulter, J. M., M. Glick, P. T. Todorov, E. Baston, M. Sami, P. Rizkallah, and B. K. Jakobsen. 2003. Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein Eng. 16: 707-711.
32. Borbulevych, O. Y., T. K. Baxter, Z. Yu, N. P. Restifo, and B. M. Baker. 2005. Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design. J. Immunol. 174: 4812-4820.
33. Tsodikov, O. V., M. T. Record, Jr., and Y. V. Sergeev. 2002. Novel computer program for fast exact calculation of accessible and molecular surface areas and average surface curvature. J. Comput. Chem. 23: 600-609.
34. Lawrence, M. C., and P. M. Colman. 1993. Shape complementarity at protein/ protein interfaces. J. Mol. Biol. 234: 946-950.
35. Collaborative Computational Project, Number 4. 1994. The CCP4 Suite: programs for protein crystallography. Acta Cryst. D 50: 760-763.
36. Khan, A. R., B. M. Baker, P. Ghosh, W. E. Biddison, and D. C. Wiley. 2000. The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site. J. Immunol. 164: 6398-6405. (Pubitemid 30408822)
37. McGaughey, G. B., M. Gagné, and A. K. Rappé. 1998. pi-Stacking interactions. Alive and well in proteins. J. Biol. Chem. 273: 15458-15463.
38. Theodossis, A., C. Guillonneau, A. Welland, L. K. Ely, C. S. Clements, N. A. Williamson, A. I. Webb, J. A. Wilce, R. J. Mulder, M. A. Dunstone, et al. 2010. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition. Proc. Natl. Acad. Sci. USA 107: 5534-5539.
39. Smith, K. J., S. W. Reid, D. I. Stuart, A. J. McMichael, E. Y. Jones, and J. I. Bell. 1996. An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 4: 203-213.
40. Armstrong, K. M., K. H. Piepenbrink, and B. M. Baker. 2008. Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes. Biochem. J. 415: 183-196.
41. Piepenbrink, K. H., O. Y. Borbulevych, R. F. Sommese, J. Clemens, K. M. Armstrong, C. Desmond, P. Do, and B. M. Baker. 2009. Fluorine substitutions in an antigenic peptide selectively modulate T-cell receptor binding in a minimally perturbing manner. Biochem. J. 423: 353-361.
42. Baxter, T. K., S. J. Gagnon, R. L. Davis-Harrison, J. C. Beck, A.-K. Binz, R. V. Turner, W. E. Biddison, and B. M. Baker. 2004. Strategic mutations in the class I major histocompatibility complex HLA-A2 independently affect both peptide binding and T cell receptor recognition. J. Biol. Chem. 279: 29175-29184.
43. Baker, B. M., R. V. Turner, S. J. Gagnon, D. C. Wiley, and W. E. Biddison. 2001. Identification of a crucial energetic footprint on the a1 helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by tax peptide/HLA-A2-specific T cell receptors. J. Exp. Med. 193: 551-562.
44. Clements, C. S., M. A. Dunstone, W. A. Macdonald, J. McCluskey, and J. Rossjohn. 2006. Specificity on a knife-edge: the alphabeta T cell receptor. Curr. Opin. Struct. Biol. 16: 787-795.
45. Rudolph, M. G., R. L. Stanfield, and I. A. Wilson. 2006. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24: 419-466.
46. Dunitz, J. D. 2004. Organic fluorine: odd man out. ChemBioChem 5: 614-621. (Pubitemid 39257082)
47. Madden, D. R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13: 587-622.
48. Kersh, G. J., M. J. Miley, C. A. Nelson, A. Grakoui, S. Horvath, D. L. Donermeyer, J. Kappler, P. M. Allen, and D. H. Fremont. 2001. Structural and functional consequences of altering a peptide MHC anchor residue. J. Immunol. 166: 3345-3354.
49. Borbulevych, O. Y., F. K. Insaidoo, T. K. Baxter, D. J. Powell, Jr., L. A. Johnson, N. P. Restifo, and B. M. Baker. 2007. Structures of MART-126/27-35 peptide/ HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition. J. Mol. Biol. 372: 1123-1136.
50. Sharma, A. K., J. J. Kuhns, S. Yan, R. H. Friedline, B. Long, R. Tisch, and E. J. Collins. 2001. Class I major histocompatibility complex anchor substitutions alter the conformation of T cell receptor contacts. J. Biol. Chem. 276: 21443-21449.
51. Liu, G. Y., P. J. Fairchild, R. M. Smith, J. R. Prowle, D. Kioussis, and D. C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3: 407-415.
52. Morgan, C. S., J. M. Holton, B. D. Olafson, P. J. Bjorkman, and S. L. Mayo. 1997. Circular dichroism determination of class I MHC-peptide equilibrium dissociation constants. Protein Sci. 6: 1771-1773.
53. Kjer-Nielsen, L., C. S. Clements, A. G. Brooks, A. W. Purcell, M. R. Fontes, J. McCluskey, and J. Rossjohn. 2002. The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization. J. Immunol. 169: 5153-5160. (Pubitemid 35217185)
54. Kjer-Nielsen, L., C. S. Clements, A. G. Brooks, A.W. Purcell, J. McCluskey, and J. Rossjohn. 2002. The 1.5 A crystal structure of a highly selected antiviral T cell receptor provides evidence for a structural basis of immunodominance. Structure 10: 1521-1532. (Pubitemid 35351492)
55. Mazza, C., N. Auphan-Anezin, C. Gregoire, A. Guimezanes, C. Kellenberger, A. Roussel, A. Kearney, P. A. van der Merwe, A. M. Schmitt-Verhulst, and B. Malissen. 2007. How much can a T-cell antigen receptor adapt to structurally distinct antigenic peptides? EMBO J. 26: 1972-1983.
56. Smith, K. J., J. Pyrdol, L. Gauthier, D. C. Wiley, and K. W. Wucherpfennig. 1998. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. J. Exp. Med. 188: 1511-1520.
57. Lang, H. L., H. Jacobsen, S. Ikemizu, C. Andersson, K. Harlos, L. Madsen, P. Hjorth, L. Sondergaard, A. Svejgaard, K. Wucherpfennig, et al. 2002. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat. Immunol. 3: 940-943.
58. Holler, P. D., and D. M. Kranz. 2003. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 18: 255-264.